BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8405227)

  • 21. Recombinant human granulocyte-macrophage colony-stimulating factor stimulates superoxide anion and hydrogen peroxide production in human neutrophils.
    Dennig D; Lam C; Fischer G; Scharf M; Knapp W
    J Hematother; 1992; 1(3):261-71. PubMed ID: 1365032
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro effects of interleukin-10, prednisolone, and GM-CSF on the non-specific immune function of human polymorphonuclear leucocytes and monocytes.
    Ziege SU; Geerdes-Fenge HF; Rau M; Buchwald U; Lode H
    Eur J Med Res; 2000 Sep; 5(9):369-74. PubMed ID: 11003971
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of GM-CSF, IL-3, and GM-CSF/IL-3 fusion protein on apoptosis of human myeloid leukemic cell line Tf-1 induced by irradiation.
    Yang SR; Wen L; Lu YQ; Gong QY; Yu R; Yao MH
    Acta Pharmacol Sin; 2004 Jan; 25(1):68-75. PubMed ID: 14704125
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of human granulocyte-macrophage colony stimulating factor/interleukin-3 fusion protein (PIXY321) on the hematopoietic toxicity associated with anti-viral drugs (zidovudine and didanosine) in vitro using normal human marrow cells.
    Gallicchio VS; Hughes NK
    Life Sci; 1995; 57(18):PL265-73. PubMed ID: 7475901
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of the GM-CSF/IL-3 fusion protein PIXY321 on bone marrow and circulating haemopoietic cells of previously untreated patients with cancer.
    Gheilmini M; Pettengell R; Coutinho LH; Testa N; Crowther D
    Br J Haematol; 1996 Apr; 93(1):6-12. PubMed ID: 8611477
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential effects of granulocyte/macrophage colony-stimulating factor (GM-CSF) in enhancing macrophage resistance to Legionella pneumophila vs Candida albicans.
    Yamamoto Y; Klein TW; Tomioka M; Friedman H
    Cell Immunol; 1997 Feb; 176(1):75-81. PubMed ID: 9070320
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hematopoietic growth factors in patients receiving intensive chemotherapy for malignant disorders: studies of granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and Flt-3 ligand (Flt3L).
    Bruserud O; Foss B; Petersen H
    Eur Cytokine Netw; 2001; 12(2):231-8. PubMed ID: 11399510
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interleukin-3 followed by GM-CSF for delayed engraftment after autologous bone marrow transplantation.
    Crump M; Couture F; Kovacs M; Saragosa R; McCrae J; Brandwein J; Huebsch L; Beauregard-Zollinger L; Keating A
    Exp Hematol; 1993 Mar; 21(3):405-410. PubMed ID: 8440338
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alteration of the functional effects of granulocyte-macrophage colony-stimulating factor on polymorphonuclear leukocytes by membrane-fluidizing agents.
    Buescher ES; McIlheran SM; Banks SM; Vadhan-Raj S
    Infect Immun; 1990 Sep; 58(9):3002-8. PubMed ID: 2167293
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Abrogation of the hematological and biological activities of the interleukin-3/granulocyte-macrophage colony-stimulating factor fusion protein PIXY321 by neutralizing anti-PIXY321 antibodies in cancer patients receiving high-dose carboplatin.
    Miller LL; Korn EL; Stevens DS; Janik JE; Gause BL; Kopp WC; Holmlund JT; Curti BD; Sznol M; Smith JW; Urba WJ; Donegan SE; Watson TM; Longo DL
    Blood; 1999 May; 93(10):3250-8. PubMed ID: 10233876
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of wortmannin on human neutrophil respiratory burst and phagocytosis.
    Santoro P; Cacciapuoti C; Palumbo A; Graziano D; Annunziata S; Capasso L; Formisano S; Ciccimarra F
    Ital J Biochem; 1998 Mar; 47(1):13-8. PubMed ID: 9646185
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prospective, randomized trial of sequential interleukin-3 and granulocyte- or granulocyte-macrophage colony-stimulating factor after standard-dose chemotherapy in cancer patients.
    Palmeri S; Leonardi V; Danova M; Porta C; Ferrari S; Fincato G; Citarrella P
    Haematologica; 1999 Nov; 84(11):1016-23. PubMed ID: 10553163
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunocytochemical analysis of tumor cells in pre- and post-culture peripheral blood progenitor cell collections from breast cancer patients.
    Ross AA; Loudovaris M; Hazelton B; Weaver CH; Schwartzberg L; Bender JG
    Exp Hematol; 1995 Dec; 23(14):1478-83. PubMed ID: 8542934
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical trials referral resource. NCI-sponsored trials of PIXY321.
    Miller LL; Cheson BD; Phillips P
    Oncology (Williston Park); 1993 Aug; 7(8):56, 62. PubMed ID: 8398635
    [No Abstract]   [Full Text] [Related]  

  • 36. Lipopolysaccharide-, granulocyte-monocyte colony stimulating factor and pentoxifylline-mediated effects on formyl-methionyl-leucine-phenylalanine-stimulated neutrophil respiratory burst in the elderly.
    Tortorella C; Polignano A; Piazzolla G; Serrone M; Jirillo E; Antonaci S
    Microbios; 1996; 85(344):189-98. PubMed ID: 8676749
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimization of culture conditions to enhance transfection of human CD34+ cells by electroporation.
    Wu MH; Smith SL; Danet GH; Lin AM; Williams SF; Liebowitz DN; Dolan ME
    Bone Marrow Transplant; 2001 Jun; 27(11):1201-9. PubMed ID: 11551032
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Granulocyte-macrophage colony-stimulating factor (GM-CSF) restores decreased monocyte HLA-DR expression after cardiopulmonary bypass.
    Börgermann J; Friedrich I; Scheubel R; Kuss O; Lendemans S; Silber RE; Kreuzfelder E; Flohé S
    Thorac Cardiovasc Surg; 2007 Feb; 55(1):24-31. PubMed ID: 17285470
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The in vivo effects of PIXY321 therapy on human monocyte activity.
    Hamilton RF; Vadhan-Raj S; Uthman M; Grey M; Holian A
    J Leukoc Biol; 1993 Jun; 53(6):640-50. PubMed ID: 8391053
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of granulocyte-macrophage colony-stimulating factor on leukocyte function in cirrhosis.
    Garcia-González M; Boixeda D; Herrero D; Burgaleta C
    Gastroenterology; 1993 Aug; 105(2):527-31. PubMed ID: 8335207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.